© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
AIxCrypto Holdings, Inc. (AIXC) stock surged +21.13%, trading at $0.90 on NASDAQ, up from the previous close of $0.74. The stock opened at $0.76, fluctuating between $0.75 and $0.92 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 0.76 | 0.92 | 0.75 | 0.90 | 624.12K |
| Sep 10, 2026 | 0.70 | 0.78 | 0.69 | 0.74 | 200.58K |
| Sep 09, 2026 | 0.70 | 0.76 | 0.66 | 0.71 | 176.32K |
| Sep 08, 2026 | 0.71 | 0.73 | 0.66 | 0.69 | 106.06K |
| Sep 04, 2026 | 0.70 | 0.74 | 0.69 | 0.71 | 102.15K |
| Sep 03, 2026 | 0.75 | 0.75 | 0.69 | 0.70 | 163.32K |
| Sep 02, 2026 | 0.77 | 0.81 | 0.76 | 0.77 | 81.51K |
| Sep 01, 2026 | 0.81 | 0.81 | 0.73 | 0.78 | 187.33K |
| Aug 31, 2026 | 0.77 | 0.92 | 0.76 | 0.81 | 613.5K |
| Aug 28, 2026 | 0.83 | 0.85 | 0.76 | 0.78 | 189.11K |
| Aug 27, 2026 | 0.93 | 0.94 | 0.80 | 0.84 | 323.2K |
| Aug 26, 2026 | 0.92 | 0.92 | 0.84 | 0.92 | 200.06K |
| Aug 25, 2026 | 0.91 | 0.94 | 0.81 | 0.93 | 460.55K |
| Aug 24, 2026 | 1.04 | 1.06 | 0.83 | 0.94 | 1.19M |
| Aug 21, 2026 | 1.24 | 1.30 | 1.11 | 1.12 | 488.97K |
| Aug 20, 2026 | 1.46 | 1.55 | 1.17 | 1.18 | 1.25M |
| Aug 19, 2026 | 1.12 | 1.62 | 1.08 | 1.55 | 5.88M |
| Aug 18, 2026 | 0.86 | 3.14 | 0.85 | 1.32 | 0 |
| Aug 17, 2026 | 0.70 | 0.75 | 0.67 | 0.71 | 112.68K |
| Aug 14, 2026 | 0.70 | 0.73 | 0.68 | 0.68 | 14.03K |
AIxCrypto Holdings, Inc. is a clinical-stage biopharmaceutical company committed to discovering and developing innovative treatments for both adult and pediatric oncology. Its leading investigational therapeutic, QN-302, is a small molecule G-quadruplexes (G4)-selective transcription inhibitor currently progressing through Phase I clinical trials for pancreatic cancer and a range of other solid tumors. The firm is also advancing Pan-RAS, a preclinical-stage program targeting advanced solid tumors. Founded in 1996 and headquartered in Carlsbad, California, the company rebranded from Qualigen Therapeutics, Inc. to AIxCrypto Holdings, Inc. in November 2025.
| Employees | 10 |
| Beta | 0.53 |
| Sales or Revenue | N/A |
| 5Y Sales Change% | N/A |
| Fiscal Year Ends | N/A |
| Sector | Technology |
| Industry | Software - Infrastructure |